Gegout P, Gillet P, Chevrier D, Guingamp C, Terlain B, Netter P
Laboratoire de Pharmacologie, URA CNRS 1288, Faculté de Médecine, Université Henri Poincaré Nancy I.
Life Sci. 1994;55(17):PL321-6. doi: 10.1016/0024-3205(94)00771-3.
A single intra-articular (ia) injection of 2 mg zymosan on D0 led to the production of acute periarticular edema followed by subacute erosive synovitis. The development of the zymosan-induced arthritis was associated with an initial loss of running activity and with an initial decrease of proteoglycan synthesis. Febrile response was present only on D1. In addition, on D20 synovial pannus led to a marked depletion of the proteoglycan content in the articular cartilage. When injected ia, IL1 beta (1 microgram) provoked similar fever and similar changes in cartilage anabolism, but did not affect cartilage proteoglycan content (D20). These results suggest that zymosan-induced synovitis in the rat combines early prostaglandin-dependent processes (edema, pain, fever) with IL1-related effects on cartilage metabolism, thus allowing evaluation of chondroprotective drugs.
在第0天关节腔内单次注射2毫克酵母聚糖会导致急性关节周围水肿,随后出现亚急性侵蚀性滑膜炎。酵母聚糖诱导的关节炎的发展与跑步活动的最初丧失以及蛋白聚糖合成的最初减少有关。发热反应仅在第1天出现。此外,在第20天,滑膜血管翳导致关节软骨中蛋白聚糖含量显著减少。当关节腔内注射白细胞介素-1β(1微克)时,会引发类似的发热以及软骨合成代谢的类似变化,但不影响软骨蛋白聚糖含量(第20天)。这些结果表明,大鼠中酵母聚糖诱导的滑膜炎将早期前列腺素依赖性过程(水肿、疼痛、发热)与白细胞介素-1对软骨代谢的相关影响相结合,从而能够评估软骨保护药物。